Ying Valerie Wu Chao, Kim Song Hon H, Khan Khurram J, Farrokhyar Forough, D'Souza Joanne, Gmora Scott, Anvari Mehran, Hong Dennis
General Surgery, McMaster University, Hamilton, ON, Canada,
Surg Endosc. 2015 May;29(5):1018-23. doi: 10.1007/s00464-014-3794-1. Epub 2014 Aug 27.
Marginal ulceration after gastric bypass surgery is a recognized complication and has been reported in 1-16% of patients. There is evidence that acidity may play a role in the disease pathophysiology and it is a common practice for bariatric surgeons to begin a prophylactic course of proton pump inhibitors (PPI), postoperatively.
MEDLINE, EMBASE, CINAHL, and the Cochrane Controlled Trials Register were searched using the most comprehensive timeline for each database up to January 2012. Studies that included patients undergoing gastric bypass who received a prophylactic course of PPI postoperatively were eligible. Two reviewers independently selected trials and extracted data. The primary outcome was the incidence of marginal ulcers diagnosed on the basis of endoscopic findings. Inverse variance random effects models were used to estimate odds ratio (OR) and weighted proportion of ulcers. Odds ratio and weighted pooled proportion with corresponding 95% confidence intervals (CI) are reported.
The strategic search identified 167 citations. A total of seven studies involving 2,917 participants were eligible for inclusion and 2,114 were used for analysis. The weighted pooled proportion of ulcer formation in PPI groups including all seven studies (four single group cohort studies and PPI arm of three cohort studies) was 5.0% [95% CI 2-10%] (N = 1,407). The OR of marginal ulcer formation comparing PPI to no PPI for three comparative cohort studies was 0.50 [95% CI 0.28-0.90, p = 0.02] (N = 1,022) with low heterogeneity (I(2) = 12%) showing that the PPI group significantly experienced twice less ulceration with PPI treatment compared to no PPI treatment.
This finding suggests a significant incremental benefit of prophylactic PPI in reducing marginal ulcer after gastric bypass surgery. Prospective randomized trials are needed to further define the role of PPI following gastric bypass surgery.
胃旁路手术后的边缘性溃疡是一种公认的并发症,在1%至16%的患者中有所报道。有证据表明,胃酸度可能在该疾病的病理生理过程中起作用,因此肥胖症外科医生在术后常规会开始使用质子泵抑制剂(PPI)进行预防性治疗。
检索了MEDLINE、EMBASE、CINAHL和Cochrane对照试验注册库,使用每个数据库截至2012年1月的最全面时间线。纳入的研究需包括接受胃旁路手术且术后接受PPI预防性治疗的患者。两名 reviewers 独立选择试验并提取数据。主要结局是根据内镜检查结果诊断的边缘性溃疡发生率。采用逆方差随机效应模型估计比值比(OR)和溃疡的加权比例。报告了比值比和加权合并比例及其相应的95%置信区间(CI)。
策略性检索共识别出167篇文献。共有7项研究涉及2917名参与者符合纳入标准,其中2114名用于分析。包括所有7项研究(4项单组队列研究和3项队列研究的PPI组)的PPI组溃疡形成的加权合并比例为5.0% [95%CI 2 - 10%](N = 1407)。三项比较队列研究中,PPI组与未使用PPI组相比边缘性溃疡形成的OR为0.50 [95%CI 0.28 - 0.90,p = 0.02](N = 1022),异质性较低(I(2)=12%),表明与未使用PPI治疗相比,PPI治疗组的溃疡发生率显著降低了一半。
这一发现表明预防性使用PPI在降低胃旁路手术后边缘性溃疡方面有显著的额外益处。需要进行前瞻性随机试验以进一步明确PPI在胃旁路手术后的作用。